Your browser doesn't support javascript.
loading
Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas.
Fanale, Michelle A; Horwitz, Steven M; Forero-Torres, Andres; Bartlett, Nancy L; Advani, Ranjana H; Pro, Barbara; Chen, Robert W; Davies, Andrew; Illidge, Tim; Uttarwar, Mayur; Lee, Shih-Yuan; Ren, Hong; Kennedy, Dana A; Shustov, Andrei R.
Afiliación
  • Fanale MA; University of Texas MD Anderson Cancer Center, Houston, TX.
  • Horwitz SM; Memorial Sloan-Kettering Cancer Center, New York, NY.
  • Forero-Torres A; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Bartlett NL; Washington University School of Medicine, Siteman Cancer Center, St. Louis, MO.
  • Advani RH; Stanford University Medical Center, Palo Alto, CA.
  • Pro B; Fox Chase Cancer Center, Philadelphia, PA.
  • Chen RW; City of Hope National Medical Center, Duarte, CA.
  • Davies A; Cancer Research UK Centre, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Illidge T; Christie Hospital NHS, Manchester, United Kingdom.
  • Uttarwar M; Seattle Genetics, Inc., Bothell, WA.
  • Lee SY; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceuticals Limited, Cambridge, MA; and.
  • Ren H; Seattle Genetics, Inc., Bothell, WA.
  • Kennedy DA; Seattle Genetics, Inc., Bothell, WA.
  • Shustov AR; University of Washington Medical Center, Seattle, WA.
Blood ; 131(19): 2120-2124, 2018 05 10.
Article en En | MEDLINE | ID: mdl-29507077

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Expresión Génica / Linfoma de Células T Periférico / Antígeno Ki-1 Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Expresión Génica / Linfoma de Células T Periférico / Antígeno Ki-1 Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2018 Tipo del documento: Article